KemPharm (KMPH) Misses Q4 EPS by 14c
Tweet
Share
E-mailGet Alerts KMPH Hot Sheet
Join SI Premium – FREE
KemPharm (NASDAQ: KMPH) reported Q4 EPS of ($0.64), $0.14 worse than the analyst estimate of ($0.50).
For earnings history and earnings-related data on KemPharm (KMPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- RBC cuts Northrop Grumman rating on slower growth, cautious defense outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
